Real-World Use of BTK Inhibitors in Chronic Lymphocytic Leukemia - Episode 5
Marc S. Hoffmann, MD, and Mazyar Shadman, MD, MPH, discuss real-world safety data for BTK inhibitors in chronic lymphocytic leukemia from EHA 2024.
Related Content: